HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.

AbstractOBJECTIVE:
We investigated two apoE mimetic peptides with similar long-term plasma cholesterol reducing abilities for their effects on atherosclerotic lesions in Western diet-fed female LDL-receptor (LDL-R) null mice.
METHODS AND RESULTS:
Single doses of peptides Ac-hE18A-NH(2) and mR18L were administered retro-orbitally to LDL-R null mice on Western diet and plasma cholesterol was measured at 10 min, 4 h, and 24 h post administration. Peptide mR18L and not Ac-hE18A-NH(2) reduced plasma cholesterol levels significantly at 4 h post administration. However, multiple administrations (100 μg/mouse twice weekly for 8 weeks) resulted in a similar reduction in plasma cholesterol. Only the plasma from the Ac-hE18A-NH(2) group had significantly reduced reactive oxygen species levels at the end of the treatment protocol. Both mR18L and Ac-hE18A-NH(2) showed reduced atherosclerotic lesion areas. However, peptide Ac-hE18A-NH(2) was significantly more effective in inhibiting atherosclerosis. Both peptides reduced total plaque macrophage load compared to the saline treated animals, with peptide Ac-hE18A-NH(2) having a greater reduction. Incubation of HepG2 cells and THP-1 monocyte-derived macrophages with both peptides in the presence of oxidized phospholipid showed that Ac-hE18A-NH(2) promotes the secretion of apoE from the cells whereas mR18L does not.
CONCLUSIONS:
Despite similar reductions in plasma cholesterol levels, Ac-hE18A-NH(2) was more effective in inhibiting lesions than mR18L, possibly due to its ability to promote the secretion of apoE from hepatocytes and macrophages.
AuthorsShaila P Handattu, Gaurav Nayyar, David W Garber, Mayakonda N Palgunachari, Candyce E Monroe, Tamara D Keenum, Vinod K Mishra, Geeta Datta, G M Anantharamaiah
JournalAtherosclerosis (Atherosclerosis) Vol. 227 Issue 1 Pg. 58-64 (Mar 2013) ISSN: 1879-1484 [Electronic] Ireland
PMID23159231 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Ac-hE18A-NH(2)
  • Apolipoproteins E
  • Lipoproteins
  • Peptide Fragments
  • Peptides
  • Reactive Oxygen Species
  • Receptors, LDL
  • mR18L peptide
  • Cholesterol
Topics
  • Animals
  • Apolipoproteins E (chemistry, metabolism)
  • Atherosclerosis (prevention & control)
  • Cholesterol (blood)
  • Female
  • Hep G2 Cells
  • Hepatocytes (drug effects, metabolism)
  • Humans
  • Lipoproteins (pharmacology)
  • Macrophages (drug effects, metabolism)
  • Mice
  • Peptide Fragments (pharmacology)
  • Peptides (pharmacology)
  • Reactive Oxygen Species (blood)
  • Receptors, LDL (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: